-
Mashup Score: 3Operationalizing Precision Oncology: The Expanding Role of the Clinical Precision Medicine Oncology Pharmacist - 12 hour(s) ago
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Source: www.pharmacytimes.comCategories: General Medicine NewsTweet
-
Mashup Score: 22SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors (DART): Non-Epithelial Ovarian Cancer - 2 day(s) ago
The role of dual checkpoint inhibition in advanced rare/ultra-rare non-epithelial ovarian cancers (NEOCs) is yet to be explored. DART is a prospective, multicenter (1,016 US sites), multi-cohort, single-arm phase II trial conducted through the Early …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
Once again, DART hits a target. https://t.co/wx5zgZD5H5 🎯 https://t.co/DohIBplJOw
-
-
Mashup Score: 25
Our data suggest that IO biomarkers should be used in patient selection for ICIs. Prospective studies are warranted.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
Is patient selection by biomarkers associated with better IO outcomes? Yes! Precision immunotherapy! https://t.co/vLRpd7h5Np https://t.co/C2MBj2uWuE
-
-
Mashup Score: 27
Comprehensive genomic profiling (CGP) and the subsequent discussions in molecular tumor boards (MTBs) are becoming an integral part of personalized cancer care. The patient with metastatic renal cell carcinoma (mRCC) presented here demonstrated an absence of a favorable response accompanied by adver …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
The latest exceptional response from an outstanding precision medicine group led by Professor Demiray in Turkey https://t.co/WgropFlqjG https://t.co/xSQSbKSpgN
-
-
Mashup Score: 3LinkedIn - 26 day(s) ago
This link will take you to a page that’s not on LinkedIn
Source: lnkd.inCategories: General Medicine NewsTweet-
RT @CureMatch: Our #ASCO25 paper Scoring approach 1st of kind predicting #clinicaltrial outcomes: https://t.co/A4n0QMfPrF using #NGS +drug…
-
-
Mashup Score: 3LinkedIn - 26 day(s) ago
This link will take you to a page that’s not on LinkedIn
Source: lnkd.inCategories: General Medicine NewsTweet-
RT @CureMatch: Our #ASCO25 paper Scoring approach 1st of kind predicting #clinicaltrial outcomes: https://t.co/A4n0QMfPrF using #NGS +drug…
-
-
Mashup Score: 9Patient rights in precision oncology: right treatment, right time, right dose, right order, right place - 1 month(s) ago
Precision oncology has facilitated a transition from a one-size-fits-all to a precise individualized approach. This Comment discusses the broader challenges in the implementation of personalized treatments to further improve patients’ outcomes, …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
Our view on patient rights in precision oncology 🔥🎯💡 https://t.co/bUusXp8Lz2 https://t.co/3Zw2y9C9xD
-
-
Mashup Score: 9Patient rights in precision oncology: right treatment, right time, right dose, right order, right place - 1 month(s) ago
Precision oncology has facilitated a transition from a one-size-fits-all to a precise individualized approach. This Comment discusses the broader challenges in the implementation of personalized treatments to further improve patients’ outcomes, …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
Our view on patient rights in precision oncology 🔥🎯💡 https://t.co/bUusXp8Lz2 https://t.co/3Zw2y9C9xD
-
-
Mashup Score: 23Gene editing helped a desperately ill baby thrive. Scientists say it could someday treat millions - 1 month(s) ago
A baby born with a rare and dangerous genetic disease is thriving after getting an experimental gene editing treatment made just for him.
Source: apnews.comCategories: General Medicine NewsTweet-
Gene editing helped a desperately ill baby thrive. Scientists say it could someday treat millions | AP News https://t.co/73SYQRwKKV
-
-
Mashup Score: 268Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly - PubMed - 3 month(s) ago
Discovering the brakes/checkpoints that cancer places on the immune system to prevent being eradicated led to the 2018 Nobel Prize and the development of multiple Food and Drug Administration-approved immune checkpoint inhibitors (ICIs). ICIs have transformed the treatment of numerous cancer types a …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
Immune checkpoint inhibitors amongst best drugs ever. Nobel Prize. End-stage cancers can be cured. But they can also cause dramatically accelerated progression pace (hyperprogression) especially in presence of EGFR alterations or MDM2 amplification https://t.co/X7p3dRpUc6 https://t.co/C5yXnc7VT0
-
Operationalizing Precision Oncology: The Expanding Role of the Clinical Precision Medicine Oncology Pharmacist: kudos to Justin Grahl, our superb precision PharmD https://t.co/Eexyze4ZlU